Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine if extending the behavioral smoking-cessation treatment period to one year will significantly improve cessation outcomes among those planning a quit attempt.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Harvard University Faculty of Medicine
Collaborators
NCT07001722 · Tobacco Addiction
NCT00491335 · HIV Infections, AIDS, and more
NCT02544360 · Tobacco Addiction, Smoking Related Diseases, and more
NCT02124200 · Tobacco Addiction
Harvard School of Dental Medicine
Boston, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions